In a recent study, we presented data on the capability of compound 1 to induce NRF2 in the human SH-SY5Y neuroblastoma cell line and to promote the endogenous upregulation of NRF2-dependent defensive genes such as NQO1 and HO-1 [24,25]. Here, NQO1 is linked to neuroblastoma.